Dr. Jessica Giddens is an INTJ-Asπ (Aspie) doctorate of nursing practice and has extensive experience in the mental health field and has served as a speaker and advisory board member in the areas of nursing leadership, psychopharmacology, bipolar disorder, major depressive disorder, attention deficit disorder, schizophrenia, tardive dyskinesia, pseudobulbar affect, binge eating disorders, autism spectrum disorders, psychopharmacogenomics, epigenetics as well as genetic testing, to name a few. Dr. Giddens is a scientific director at Knowfully Learning Group a part of CME Outfitters, and Healthcare consultant, in addition to being a neuroscience nerd and mom.

As a nurse she has worked in multiple areas including community mental health, inpatient psychiatric units including adult, acute adult, geriatric, and child and adolescents. In addition to her extensive experience in psychiatry, she has also worked as a nursing supervisor and as part of an acute care float team gaining experience in multiple inpatient medical units.

Despite her own struggles with Autism and juggling work-life balance with single motherhood, throughout her training and career, she has received several scholarships, honors, and awards. Jessica also is recognized as an industry and national thought leader and has been invited to be an advisory board member for psychiatric research and development companies such as Otsuka, Sunovion, Allergan, Abbvie, Teva, and Avanir. As an advocate for neurosicence nomenclature and routine use of psychopharmacogenomics in practice, she has spoken for Genomind and is a member of the International Society of Psychiatric Genetics. She has also taken part in industry publications and has participated as a co-host on a local health radio show. She has also developed more interest in brain-computer interfaces, artificial intelligence, and digital therapeutics. Jessica feels she has a diverse experience and passion in neuropsychiatry and strives to decrease stigma and promote education and research in the field. She hopes that her passion for psychiatry, the science of neuropsychopharmacology, neurobiology, neuropathology, and neuropsychopharmacogenomics; and her research will continue to inspire other nurses to expand the horizons for psychiatric nurses everywhere, and someday hopes to be one of the first doctorly prepared nurse practitioners to be accepted as a member of the American College of Neuropsychopharmacology and become an even more influential leader.